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ABSTRACT 
 
DNAzymes are catalytic DNA which bind to target RNA by complementary sequence arms on a Watson-
Crick basis and cleave RNA at specific sites. Potential therapeutic applications require DNAzymes that can 
efficiently cleave their target. Here we investigate factors affecting DNAzyme cleavage efficacy against the 
muscle acetylcholine receptor (AChR) α-subunit. The 10-23 DNAzymes cleave at Y-R nucleotide motifs, 
where R is A or G, and Y is U or C. Targeting a series of sites within different regions of the full-coding 
length cRNA under simulated physiological conditions found that the most efficient motifs for cleavage were  
in the hierarchy: GU ≥ AU > GC >>> AC. This order is consistent with the kinetic analysis of short synthetic 
RNA substrates that have the same binding arms but different cleavage sites. DNAzymes with longer sym-
metric binding arms were more efficient than those with shorter arms, while asymmetric DNAzymes with a 
longer arm I were also more efficient, suggesting a dominant role for arm I in determining cleavage activity. 
Modification of one DNAzyme by inverted thymidine (iT) or locked nucleic acids (LNA) showed the LNA-
modified DNAzyme gave efficient silencing of AChR expression in HEK 293 cells. Our data demonstrate 
the usefulness of screening in vitro for an efficient DNAzyme prior to cellular applications. 
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INTRODUCTION 
 
DNAzymes are catalytic DNA analogues of the naturally 
occurring hammerhead ribozymes that cleave RNA sub-
strates in a sequence-specific manner (Santoro and Joyce, 
1997).  DNAzymes, like  hammerhead  ribozymes, have  a 
structure comprised of three domains. A central conserved 
motif  contains  the  catalytic  domain  and  is  activated  by 
metal  ions  such  as  Mg
2+  cations.  The  catalytic  core  is 
flanked by two recognition-binding arms (arms I and II) 
that bind to target RNA on a Watson-Crick basis. Santoro 
and Joyce identified two catalytic DNAzyme motifs, 8-17 
and 10-23 (Santoro and Joyce, 1997). Each enzyme motif 
recognises nucleotide residues within the target RNA re-
sulting in phosphodiester bond cleavage and the genera-
tion of two RNA fragments. 
 
DNAzymes have been used to suppress pathogenic genes in a 
growing number of disease models (reviewed in Khachigian, 
2002; Achenbach et al, 2004) and in other in vivo applications 
(Zhang et al, 2004;  Liu  et  al, 2005).  Understanding  the 
design of efficient DNAzymes is of growing interest in the 
gene therapy field. The cleavage efficiency depends on the 
properties of the target, such as its structure and therefore 
cleavage  site  accessibility,  and  on  properties  of  the 
DNAzyme, principally its catalytic activity and how this is  
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optimised. For example, the RY rule for 10-23 DNAzymes 
gives four potential cleavage sites: GU, GC, AU and AC 
(Santoro  and  Joyce,  1997),  which  may  be  cleaved  with 
different efficiencies. Screening for an efficient DNAzyme 
in vitro may give a good indication of its potential cellular 
efficacy. Reported in vitro optimisation of DNAzyme ca-
talysis has mostly used non-physiological high Mg
2+ con-
centrations  and/or  on  short  substrate  target  molecules 
(Cairns et al, 2000; Toyoda et al, 2000; Basu et al, 2000; 
Sriram and  Banerjea, 2000; Sioud and  Leirdal, 2000; Liu 
et al, 2001; Kurreck et al, 2002; Wang et al, 2002; Cairns 
et al, 2003; Schubert et al, 2003; Schubert et al, 2004).  
However,  screening  for  efficient  DNAzymes  using  full-
length in vitro transcribed RNA (cRNA) under simulated 
physiological conditions is likely, in many cases, to be of 
greater direct relevance for therapeutic application. 
 
The muscle acetylcholine receptor (AChR) is expressed at 
the neuromuscular junction, and plays the principal role in 
nerve to muscle signal transmission. A number of muta-
tions have been characterised in the AChR α-subunit gene 
which affect receptor function and give rise to congenital 
myasthenic  syndromes  (Croxen  et  al,  1997;  Engel  and 
Sine, 2005). Some of these mutations were targeted in an 
initial report investigating the potential therapeutic appli-
cations  of  DNAzymes  and  considerable  variation  in 
cleavage efficiencies was encountered (Abdelgany et al, 
2005). In this study, we investigate the factors affecting 
DNAzyme  cleavage  activity  using  full-coding  length 
cRNA  transcripts  under  simulated  physiological  condi-
tions and highlight parameters that should be taken into 
account  prior  to  the  design  of  DNAzymes  for  cellular 
applications. 
 
MATERIALS AND METHODS 
 
Design and synthesis of DNAzymes and their synthetic 
RNA substrates 
DNAzymes  bearing  the  10-23  catalytic  motif  were  de-
signed against the full-coding length of AChR α-subunit 
cRNA  and  were  obtained  from  Invitrogen 
(http://www.invitrogen.com).  Chemically  modified 
DNAzymes were synthesised by incorporating a modified 
nucleotide either side of the binding arms. Two types of 
modifications  were  used:  3'-3'-inverted  thymidine  (iT) 
obtained from Invitrogen and locked nucleic acids (LNA) 
obtained  from  Proligo  (http://www.proligo.com).  RNA 
oligonucleotides were synthesised on a DNA/RNA synthe-
siser  (model  394;  PE  Applied  Biosystems,  Foster  City, 
CA). The crude deprotected oligonucleotides were purified 
on an open column and then purified on a 20% (w/v) poly-
acrylamide  gel  that  contained  7  M  urea,  and  RNA  was 
eluted with milli-Q water (Millipore, Billerica, MA) and 
desalted by passage through a NAP10 column (Amersham 
Pharmacia Biotech AB, Uppsala, Sweden). DNAzymes for 
short  substrates  were  obtained  from  Hokkaido  System 
Science  Co  Ltd  (Sapporo,  Hokkaido,  Japan)  and  Espec 
Oligo Service Corp (Ibaraki, Japan). DNAs were purified 
on a 20% (w/v) polyacrylamide gel and preparations were 
desalted  on  a  NAP10  column.  To  facilitate  DNAzyme 
nomenclature, DNAzymes will be referred to, for example, 
as  808GU(13+9),  where  808  is  the  nucleotide  position 
within the cRNA target transcript, GU the cleavage site 
sequence, and  (13+9) represents the lengths of arm II and 
arm I respectively, i.e., arm II is 13 nucleotides in length 
and arm I is 9 nucleotides in length (see list of DNAzymes 
and sites within the AChR α-subunit sequence targeted in 
Table 1). 
 
RNA substrate preparation, in vitro transcription and 
in vitro cleavage reactions 
cDNA  encoding  the  human  AChR  α-subunit  was  sub-
cloned into pcDNA3.1hygro (Invitrogen). The full coding 
sequence  of  α-subunit  was  synthesised  from  its  cDNA 
using the Megascript™ T7 in vitro transcription kit (Am-
bion Biosciences) to generate 
32P- labelled RNA substrate 
(cRNA). 
 
To  determine  DNAzyme  catalytic  activity, target  cRNA 
and  DNAzyme  were  incubated under  simulated  physio-
logical conditions of 2 mM MgCl2, 150 mM KCl, 50 mM 
Tris-HCl, pH 7.5, at 37° C (Santoro and  Joyce, 1997)  for 
4 hr. Certain reactions were also performed at 10, 25 and 
50 mM Mg
2+. The reactions were carried out under single 
turn over conditions using a ratio for DNAzyme:substrate 
of 10:1.  Reactions were terminated by adding 90 µl stop 
buffer  (95%  (v/v)  formamide,  0.025%  (w/v)  xylene 
cyanol, 0.025% (w/v) bromophenol blue, 18 mM EDTA 
and 0.025% (w/v) SDS) and were run on a 6% (w/v) dena-
turing polyacrylamide gel.  
 
Analysis of DNAzyme cleavage efficiency 
Gels were dried and exposed overnight to a phosphor stor-
age screen and scanned in a PhosphorImager (Fuji). The 
cleavage efficiency of labelled transcripts was quantified 
by measuring the band intensity of the cleaved products 
(P1 and P2) and the remaining substrate (S). The percent-
age cleavage (%C) was calculated using the equation %C 
= [(P1+P2)/ (P1+P2+S)] x 100 where P1 and P2 are the 5’ 
and 3’products, S is the substrate. This equation is modi-
fied  from  Werner  and Uhlenbeck (1995). The  data  pre-
sented are the means  of at least 3 repeated experiments 
unless otherwise stated.   
 
Cell culture and transfection 
cDNAs encoding the AChR α, β,
 δ and ε subunits were 
co-transfected with respective DNAzymes into HEK 293 
cells grown in 6-well tissue culture plates. A total of 3 µg 
of  AChR  subunit  cDNA  and  700 pmol  of  DNAzymes 
were used per well. Surface AChR expression was de-
termined by incubating the cells, 48 hr post-transfection, 
in 10 nM 
125I-α-bungarotoxin (BuTx) for 1 hr, followed 
by washing in PBS. Cells were removed from the plate 
and  125I-α-BuTx  binding  measured  using  a  gamma 
counter. 
 
RESULTS 
 
DNAzyme structure: cleavage sites 
The cleavage efficiencies for DNAzymes targeting differ-
ent cleavage sites within the AChR α-subunit cRNA were 
investigated in three regions (Figure 1, regions A, B and 
C). In order to minimise the effect of the RNA secondary 
structure, cleavage sites close to each other within each 
region  were  targeted.  In  region  A  these  were  463GU, 
472AU  and  476AC.   Symmetrical  (10+10)   DNAzymes   
© Abdelgany et al | Journal of RNAi and Gene Silencing | October 2005 | Vol 1, No 2 | 88-96 | OPEN ACCESS 
90 
Table 1. DNAzyme nomenclature and target sequences used in this study, with cleavage sites in bold.  
 
Region  DNAzyme  Target sequence 5' - 3' 
        Arm II        cleavage site       Arm I 
463GU(10+10)          GACGGCUCU GU CGUGGCCAU 
463GU(13+9)  CUACGACGGCUCU GU CGUGGCCA 
463GU(9+13)      GACGGCUCU GU CGUGGCCAUCAA 
472AU(10+10)     UGUCAUGGCC AU CAACCCGGA 
472AU(13+9)  CUCUGUCAUGGCC AU CAACCCGG 
472AU(9+13)      GUCAUGGCC AU CAACCCGGAAAG 
A 
476AC(10+10)     AUGGCCAUCA AC CCGGAAAGC 
     
685AC(13+9)     CUCCUUCUUCUUA AC UGGCCUGG  
694GU(13+9)    CUUAACUGGCCUG GU AUUCUACC 
696AU(13+9)    UAACUGGCCUGGU AU UCUACCUG 
765GU(13+9)   UGUCUUUGACUGU GU UCCUUCUG 
B 
765GU(9+13)       UUUGACUGU GU UCCUUCUGGUCA 
     
799AC(13+9)           GCUGAUCCCCUCC AC GUCCAUUG  
801GU(13+9)   UGAUCCCCUCCAC GU CCAUUGCU 
801GU(9+13)       CCCCUCCAC GU CCAUUGCUGUGC 
805AU(13+9)   CCCCTCCACGTCC AU UGCUGUGC 
808GC (13+9)   CUCCACGUCCAUU GC UGUGCCCU 
811GU(10+10)     GUCCAUUGCU GU GCCCUUGAU 
811GU(13+9)   CACGUCCAUUGCU GU GCCCUUGA 
811GU(9+13)       UCCAUUGCU GU GCCCUUGAUUGG 
C 
811GU(13+13)   CACGUCCAUUGCU GU GCCCUUGAUUGG 
     
 694GU(7+7)        UGGCCUG GU AUUCUA 
 694AU(7+7)        UGGCCUG AU AUUCUA 
 694GC(7+7)        UGGCCUG GC AUUCUA 
Synthetic RNA substrates  
 694AC(7+7)        UGGCCUG AC AUUCUA 
     
463GU(10+10)LNA     CGACGGCUCU GU CGUGGCCA  Chemically modified 
DNAzymes 
463GU(10+10)iT    TCGACGGCUCU GU CGUGGCCAT 
 
 
 
against these sites were incubated with AChR α-subunit 
cRNA under simulated physiological conditions for 4 hr. 
The results showed that the substrate was cleaved at the 
GU, AU and AC sites with efficiencies of 62%, 73% and 
9%, respectively. The AC site was significantly poor com-
pared to GU and AU sites (P < 0.001 for each) (Figure 1, 
region A). Region B was targeted at four cleavage sites: 
685AC, 689GC, 694GU and 696AU, with asymmetrical 
(13+9)  DNAzymes.  Sites  GU  and  AU  were  efficiently 
cleaved with over 90% cleavage (Figure 1, region B).  By 
contrast, the AC and GC sites showed significantly lower 
levels of cleavage than the GU and AU sites (P < 0.001). 
In  the  third  region,  region  C,  cleavage  sites  799AC, 
801GU, 805AU and 808GC were targeted. The AC target 
site was cleaved least (P < 0.001), whereas GU, GC and 
AU sites were efficiently cleaved (Figure 1, region C). In 
this region the GC site showed 54% cleavage efficiency in 
contrast to the result from region B. Cleavage at the AC 
sites was slightly improved if the reaction conditions used 
higher Mg
2+ concentrations (10 and 50 mM) but was still 
far below levels of cleavage at the GU and AU sites (data 
not shown).  
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Figure 1. Efficiency of 10-23 DNAzyme at different cleavage sites. A series of different cleavage sites within regions A, B and C of 
the AChR α-subunit target sequence was studied to investigate 10-23 DNAzyme cleavage efficiency. Each panel shows the substrate 
sequence targeted by each DNAzyme. Cleavage was carried out under simulated physiological conditions of 2 mM Mg
2+ for four 
hours. In region A three cleavage sites were targeted (AU, GU and AC). In regions B and C four cleavage sites (AC, GC, GU and 
AU) were targeted. 
 
 
We next performed a time course of enzymatic cleavage 
under  simulated  physiological  conditions.  DNAzymes 
targeting  region  A,  463GU(10+10),  472AU(10+10)  and 
476AC(10+10)  were  assessed.  For  the  AU-targeted 
DNAzyme, 50% of the substrate was cleaved within 30 
min,  whereas  for  the  GU-targeted  DNAzyme  this  was 
achieved  after  approximately  1  hr,  and  the  AC-targeted 
DNAzyme showed minimal cleavage never reaching 50% 
(Figure 2A). After 8 hr, maximum cleavage of the sub-
strate of 90% and 77% for the AU and GU sites respec-
tively had been achieved, whereas the AC site was still 
cleaved  by  less  than  14%.  In  region  B,  the  DNAzyme 
694GU(13+9)  demonstrated  the  highest  cleavage  effi-
ciency, over 50% of substrate was cleaved after 15 min, 
increasing to 74% cleavage after 30 min and almost reach-
ing completion by 4 hr. By contrast, 685AC(13+9) showed 
insignificant cleavage after eight  hours (Figure  2 B).  In 
region  C,  DNAzymes  801GU(13+9)  and  808GC(13+9) 
showed similar catalytic behaviour, achieving about 50% 
cleavage after approximately three hours, while DNAzyme 
799AC(13+9) yielded less than 13% cleavage after eight 
hours (Figure 2 C). 
 
Kinetic analysis of cleavage efficiency for the alterna-
tive RY nucleotide pairs 
The above results suggest a hierarchy for cleavage effi-
ciency as follows: AU = GU > GC >>> AC. To confirm 
this hierarchy, we investigated their cleavage efficiency 
using kinetic analysis. 694GU was found to be the most 
efficiently cleaved site and so was used for this analysis. 
Four  short  RNA  substrates  were  synthesised  differing 
only  by  the  cleavage  site  residues.  Thus,  the  15-
nucleotide  sequence  UGGCCUG  GU  AUUCUA  was 
used as substrate and the GU cleavage site replaced by 
AU,  GC  or  AC  to  give  four  respective  separate  RNA 
oligonucleotides.  Each  of  the  four  synthetic  substrates 
was incubated with the relevant DNAzyme and cleavage 
reactions  were  performed  under  DNAzyme-saturated 
(single-turnover) conditions at 37
oC. In order to exclude 
any  effects  from  low  Mg
2+  levels,  cleavage  reactions 
were  performed  in  high  Mg
2+  concentration  (25  mM 
MgCl2).  The  cleavage rates were analysed for each  of 
the DNAzymes by calculating the kobs (min
-1) ×10
-3 (Ta-
ble 2). The results show that the GU site cleaved twice 
as fast as the AU, and the AU was 75 times faster than 
the GC. By contrast, the AC site was the slowest.  From 
the results of this experiment the hierarchy for cleavage 
efficiency  may  be  arranged  in  the  descending  order 
GU>AU> GC>AC. 
 
 
Table 2. Cleavage rate constants of substrates were measured in 
50 mM Tris-HCl (pH 7.0) and 25 mM MgCl2 under enzyme-
saturated (single-turnover) conditions at 37
oC. 
 
DNAzyme  Cleavage site  kobs (min
-1) × × × ×10
-3 
 
694GU(7+7) 
 
GU  63.30 
 
694AU(7+7) 
 
AU  30.80 
 
694GC(7+7) 
 
GC  00.41 
 
694AC(7+7) 
 
AC  00.14 
Region A
5’ CGACGGCUCU GU CGUGGCC AU CA AC CCGGAAAGC 
463 472 476
Region B
CUUCUCCUUCUUA AC UG GC CUG GU AU UCUACCUG 
685 689 694 696
Region C
CUGAUCCCCUCC AC GU CC AU U GC UGUGCCCU 3’
799 801 808 805
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Figure 2. Time course of cleavage reactions. Reactions under simulated physiological conditions were followed with respect to incu-
bation time for DNAzymes in each of the target regions. Samples were analysed at 0.25, 0.5, 1, 2, 3, 4, and 8 hr. Lane S represents 
uncleaved full length substrate. (A) DNAzymes targeting cleavage sites (GU, AU and AC) in region A, example autoradiographs of 
in vitro cleavage reactions, and plots of the % cleavage. (B) DNAzymes targeting cleavage sites (AC and GU) in region B, example 
autoradiographs of in vitro cleavage reactions and plots of % cleavage. (C) DNAzymes targeting cleavage sites (AC, GU, and GC) in 
region C, autoradiographs of in vitro cleavage reactions and plots of % cleavage. 
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DNAzyme structure: length and symmetry of the bind-
ing arms  
DNAzyme catalytic activity is influenced by the stability 
of binding to the RNA substrate (Ota et al, 1998; Lustig et 
al, 1995) and thus will be affected by the length of the 
binding  arms.  We  first  studied  symmetrical  DNAzymes 
targeted to the 801GU site. A symmetrical 801GU(10+10) 
DNAzyme yielded 41% substrate cleavage after 4 hr, and 
lengthening  the  binding  arms  in  the  DNAzyme 
801GU(13+13) increased the cleavage efficiency to 77% 
(Figure  3A).  Two  symmetrical  DNAzymes 
805AU(10+10) and 805AU(13+13) yielded 55% and 76% 
cleavage respectively, but when the length of the arms was 
increased  to  805AU(21+21)  cleavage  efficiency  was  re-
duced to 40% (data not shown). 
 
To investigate further the effect of each binding arm, two 
DNAzymes with asymmetrical binding arms, 765GU(13+9) 
and 765GU(9+13), were designed to target a short 459 nu-
cleotide  AChR  α-subunit  cRNA  substrate.  The 
765GU(13+9)  DNAzyme  cleaved  47%  of  the  target 
whereas the 765GU(9+13) DNAzyme cleaved with a higher 
efficiency  of  75%  (Figure  3B(i)).  We  then  examined  the 
effect of alternative lengths of arm I and arm II on catalytic 
activity  by  designing  pairs  of  asymmetric  DNAzymes, 
(13+9)  and  (9+13)  and  targeting  the  full  length  AChR 
 
 
 
A:                B: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Binding arm length and asymmetric DNAzymes. (A) The 801GU cleavage site in region C was targeted by two 
DNAzymes with differing binding arm lengths (13+13 and 10+10) under simulated physiological conditions. Example autoradio-
graphs of in vitro cleavage reactions for the 13+13 and 10+10 DNAzymes are shown.  The cleavage efficiency after four hours, de-
termined from four independent experiments in each case, is shown following quantification of 
32P signals by phosphoimage analy-
sis. (B) Pairs of asymmetrical DNAzymes with differing binding arm lengths were targeted at the five different cleavage sites using 
simulated physiological conditions. In each case example autoradiographs of in vitro cleavage reactions and the cleavage efficiency 
after four hours, determined from four independent experiments, are shown. (i) Cleavage of a short 459 nucleotide AChR α-subunit 
cRNA substrate at the 764GU site, by 764GU(13+9) and 764GU(9+13) DNAzymes. (ii) Cleavage of full-length α-subunit cRNA 
substrate at two cleavage sites 801GU and 811GU. (iii) Cleavage of full-length α-subunit cRNA substrate at two cleavage sites 
463GU and 472AU. (iv) Cleavage of a full-length α-subunit cRNA substrate at the 764GU site at 10 mM Mg
2+. 
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α-subunit cRNA at sites in regions A and C. GU or AU 
cleavage sites were targeted in the three different regions 
and in each case the DNAzyme with longer arm I (9+13) 
gave greater cleavage of the substrate (Figure 3B). Pairwise 
comparison  of  (9+13)  versus  (13+9)  DNAzymes  for  the 
five target sites showing greater cleavage efficiency gave a 
statistically significant p value of 0.00002 by Student’s t-
test.  This  greater  cleavage  efficiency  for  asymmetric 
DNAzymes with longer arm I was also maintained when 
the Mg
2+ levels were increased to 10 mM (Figure 3B(iv)).  
 
Cellular cleavage of α α α α-subunit AChR  
Chemical  modifications  may  be  used  to  stabilise 
DNAzymes against attack by cellular nucleases. The cellu-
lar efficacy of modified DNAzymes targeted in region A 
was assessed. Modified 463GU(10+10) DNAzymes with 
either 3'-3'-inverted thymidine (iT) or locked nucleic acids 
(LNA) containing a 2'-O, 4'-C methylene bridge were first 
assessed in vitro. Modifying the DNAzyme with the (iT) 
dramatically reduced its catalytic activity: 13% cleavage 
versus 67% for the standard DNAzyme (Figure 4 A). By 
contrast, the LNA-DNAzyme gave enhanced cleavage of 
the  cRNA  substrate,  87%  versus  67%.  The  modified 
DNAzymes were next targeted at AChR α-subunit mRNA 
transcript in cells. We first established efficient transfec-
tion into HEK 293 cells using a FITC-labelled DNAzyme 
(Figure 4B). Subsequently, cDNA encoding the AChR α, 
β, δ and ε subunits were co-transfected with standard iT- 
or LNA-DNAzymes into HEK293 cells and the expression 
of AChR was determined by measuring the binding of 
125I-
labelled α-bungarotoxin (
125I-α-BuTx) to the surface of the 
cells.  Measurements  were  normalised  to  surface  expres-
sion in cells co-transfected with a non-specific DNAzyme. 
Whereas  both  the  standard  DNAzyme  and  the  iT-
DNAzyme show only a modest effect on AChR expres-
sion, the LNA-DNAzyme efficiently down-regulated sur-
face expression of the AChR to only 13% of the positive 
control  value.  Co-transfection  of  an  LNA-modified 
DNAzyme targeted at EGFP had no inhibitory effect on 
surface AChR expression (Figure 4C). 
 
DISCUSSION 
 
Understanding  the  requirements  for  optimal  DNAzyme 
activity under cellular conditions will establish the knowl-
edge  base necessary for efficient in vivo applications of 
these molecules. We were therefore interested to optimise 
the cleavage process for a cRNA transcript under simu-
lated physiological conditions, and in a cellular model. As 
a model we have studied the AChR α-subunit cRNA tran-
script as a target substrate, in which pathogenic mutations 
have  been  previously  described  (recently  reviewed  in 
Engel  and  Sine,  2005).  Here  we  demonstrate  efficient 
cleavage  of  the  target  RNA  transcript  in  regions  where 
mutations  have  been identified.  10-23  DNAzymes  show 
preferential cleavage, at  the four  possible  cleavage sites 
that can be arranged in the following hierarchical order: 
GU ≥ AU > GC >>> AC. This order is closely aligned to 
the AU = GU ≥ GC >> AC hierarchy reported by Cairns et 
al (2003), where the reduced activity against AC was as-
cribed to the stronger Watson-Crick interaction of rC-dG, 
which  leads  to  reduced  catalysis.  Modification  of 
DNAzymes which weakened the Watson-Crick interaction  
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Figure 4 Cleavage and cellular silencing of AChR α-subunit 
cRNA by modified DNAzymes. (A) In vitro cleavage by modi-
fied DNAzymes of full coding region AChR α subunit cRNA 
using a standard DNAzyme, inverted T (iT) and locked nucleic 
acid (LNA) modified DNAzymes. Cleavage was performed un-
der simulated physiological conditions for 4 hr. Reaction prod-
ucts were size fractionated on a 6% (w/v) sequencing gel and 
cleavage was determined by phosphorimage analysis. % cleavage 
was determined from three independent experiments. (B) Trans-
fection of DNAzymes into HEK 293 cells.  HEK 293 cells were 
transfected with varying amounts of FITC-labelled 
463GU(10+10) DNAzyme (green) and visualised using confocal 
microscopy 48 hr post-transfection. Cells were visualised by 
immunoflorescence of a membrane-protein CD44  (red). (C) 
Silencing of AChR expression by an LNA-modified DNAzyme. 
cDNA encoding the human muscle AChR α, β, δ and ε subunits 
were co-transfected with a non-specific DNAzyme (NS-Dz), 
standard DNAzyme (Dz), iT-DNAzyme (iT-Dz) or LNA-
DNAzyme (LNA-Dz) into HEK 293 cells. Total 
125I- α-BuTx 
binding to the surface of the transfected HEK 293 cells was 
measured 48 hr post-transfection. Results are normalised to 
125I- 
α-BuTx binding to the α β δ ε + NS-Dz transfection and represent 
the mean ± SD of five experiments. 
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at this residue dramatically enhanced activity against the 
AC cleavage site.  As expected, longer symmetrical bind-
ing  arms  confer  greater  cleavage,  but  our investigations 
also revealed that arm I plays a dominant role in determin-
ing activity.  Based upon our in vitro studies, we were able 
to  create  an  LNA-modified  DNAzyme  that  was  highly 
effective in silencing AChR expression in HEK 293 cells.  
 
Cleavage sites 
Comparison of the four 10-23 DNAzyme sites, AC, AU, 
GC and GU, in three different regions revealed differences 
in their cleavage efficiencies as follows: GU ≥ AU > GC 
>>> AC. Kinetic analysis of cleavage efficiency used short 
synthetic substrates in order to minimize the influence of 
RNA secondary structure. Nevertheless we found the re-
sults  using  cRNAs  harbouring  the  full  AChR  α-subunit 
coding  region  under  simulated  physiological  conditions 
correlate  well  with  our  results  from  the  kinetic  analysis 
and with  the  previous  reported  analysis  of the  cleavage 
sites  in  short  RNA  substrates  (Cairns  et  al,  2003).  The 
difference  in  cleavage  efficiency  obtained  between  the 
regions, A, B and C of the AChR  α-subunit mRNA are 
likely due to differing secondary structure and sequence 
context of the binding arms. Within the three regions we 
observed little difference between GU and AU cleavage 
sites, but did encounter an unexpectedly efficient GC site 
in region C. Our data support previous findings (Cairns et 
al,  2003)  of  AC  sites  being  the  least  efficient  for 
DNAzyme cleavage and may well provide an alternative 
explanation for a previous report in which lack of cleavage 
by two DNAzymes targeting AC sites in the TAT RNA 
HIV-1  gene  was  attributed  to  RNA  secondary  structure 
(Unwalla and  Banerjea, 2001).  
 
Asymmetrical DNAzymes 
 The  cleavage  process  depends  on  DNAzyme-substrate 
binding  substrate  (Ota  et  al,  1998;  Lustig  et  al,  1995), 
which, in turn, is affected by the length of the DNAzyme 
recognition arms.  Not surprisingly, under single turnover 
conditions, long-armed DNAzymes were found to be more 
efficient than short ones in agreement with previous find-
ings (Shimayama et al, 1995; Oketani et al, 1999). How-
ever, the respective arm length of arms I or II seems also 
to  play  a  role  in  determining  the  DNAzyme  activity  as 
observed  in  comparing  asymmetric  DNAzymes.  Those 
asymmetric molecules with a shorter arm I showed lower 
catalytic efficiency than those with a shorter arm II. In our 
results this effect was consistent at five different cleavage 
sites with pairs of asymmetric DNAzymes under simulated 
physiological conditions (Figure 3B). Interestingly, a domi-
nant role for arm I in determining catalytic activity has been 
reported for the hammerhead ribozyme equivalent (helix I) 
(Hertel et al, 1996). Crystallographic studies have revealed 
that  hammerhead  ribozyme  helices  I  (equivalent  to 
DNAzyme arm I) and II (the catalytic core) are required to 
be in close proximity for function (Tuschl et al, 1994; Lus-
tig et al, 1995), and recently it was also shown that some 
residues in helix I (e.g., positions 1.5 and 1.6) specifically 
bind the catalytic core (Dunham et al, 2003). Given that the 
catalytic mechanism for DNAzymes is thought to be similar 
to that of hammerhead ribozymes (He et al, 2002), our data, 
together with these reports, suggest a dominant role for arm 
I  over  arm  II in  determining catalytic  efficiency.  This  is 
consistent with the observation that the activity of asymmet-
rical DNAzymes is more sensitive to mismatches in arm I 
than arm II (Abdelgany et al, 2005). 
 
Silencing of AChR expression in HEK293 cells 
Preventing the rapid cellular degradation of DNAzymes is 
crucial for most therapeutic applications. We show that an 
LNA-modified DNAzyme has a significant cellular effi-
cacy resulting in efficient silencing of AChR in cells with 
a reduction in surface 
125I-α-BuTx binding to 13% of the 
control. To examine the effects of chemical modifications 
on  cleavage  efficiency,  we  selected  an  efficient 
DNAzyme, 463GU(10+10) and modified it either by in-
corporating inverted thymidines (iT) or the locked nucleic 
acid (LNA) method.  Chemical modifications are likely to 
influence DNAzyme catalytic activity; the LNA modifica-
tion has previously been shown, for example, to enhance 
catalytic  activity  (Vester  et  al,  2002).    The  modified 
DNAzymes were first tested in vitro, and while  the iT-
DNAzyme  activity  dropped  dramatically,  the  LNA-
DNAzyme activity increased. The stronger binding affin-
ity of LNA/RNA duplex over DNA/RNA (Crinelli et al, 
2002) might account for this. The reduced activity of the 
iT-DNAzyme was unexpected since previous reports have 
found  this  modification  has  minimal  effects  on  kinetic 
behaviour (Schubert et al, 2003). When tested in cells, the 
gene silencing of the modified DNAzymes correlated well 
with their in vitro activity, contrasting with the unmodified 
DNAzyme,  which showed little silencing in  the cellular 
environment. This may well be due to resistance to nucle-
ase degradation conferred by the LNA modification. Al-
though not strictly comparable, the gene silencing effect 
achieved  in  HEK293  cells  with  the  LNA-modified 
DNAzyme was similar to the gene silencing for the AChR 
expression  in HEK  293  cells  achieved  using siRNA  di-
rected against the AChR α-subunit mRNA (Abdelgany et 
al, 2003). Our results highlight the usefulness of defining 
optimal DNAzymes in vitro prior to cellular applications. 
 
CONCLUSIONS 
 
• 10-23 DNAzyme sites were cleaved in the hierarchy GU 
≥ AU > GC >>> AC in agreement with results of Cairns 
et al (2003). 
 
• Asymmetric DNAzymes with a longer arm I were more 
efficient than those with a longer arm II, suggesting a 
role for arm I in enhancing the DNAzyme activity. 
 
• In vitro testing of DNAzymes under simulated physio-
logical conditions may help identify efficient DNAzymes 
for cellular applications. 
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